Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Vectura Says Year-To-Date Performance In Line With Expectations

Tue, 19th Aug 2014 10:00

LONDON (Alliance News) - Vectura Group PLC said Tuesday that its financial performance and the progression of its product pipeline in the year-to-date has been in line with its expectations.

The pharmaceutical company said that following its acquisition of Activaero GmbH in March, the integration of the business is progressing well.

In the year-to-date the company has signed a development and license agreement for the US rights to its VR506 asthma treatment with its undisclosed US partner. Under the agreement Vectura will provide support for the US development of VR506, for which it will get an initial payment of USD4 million and up to USD8 million on the achievement of milestones.

Further fees may be payable to Vectura if the programme progresses beyond a pre-defined milestone, it said, and the company will also receive a royalty from all US sales of VR506.

It also made progress with its VR315 generic programme for asthma and chronic obstructive pulmonary disease, triggering a USD1.5 million milestone in June related to its development. The roll-out of the Seebri Breezhaler and Ultibro Breezhaler continued, with partner Novartis International AG reporting sales of USD67 million and USD36 million, respectively, for the first two quarters of 2014.

Novartis expects the US filing of the two treatments to take place in the fourth quarter of 2014.

In April, the company triggered a GBP2 million milestone from its licence agreement with GlaxoSmithKline PLC. Under this deal it also receives royalties on the sales of Glaxo's Breo Relvar Ellipta and Anoro Ellipta treatments for up to GBP13 million per year. During the first two quarters of 2014, Glaxo reported sales of GBP11 million for Breo Relvar Ellipta, and GBP5 million for Anoro Ellipta.

"Vectura is well positioned to continue its transition towards creating a leading specialty pharmaceutical company focused on airways disease," said Chief Executive Chris Blackwell in a statement.

Vectura will announce its interim results on November 18.

Shares in Vectura were trading up 0.1% at 143.12 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
1 Oct 2021 10:22

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

Read more
29 Sep 2021 09:23

UPDATE 2-Morrisons takeover battle will go to UK auction on Oct. 2

(Adds background)LONDON, Sept 29 (Reuters) - A $9.5-billion fight for British supermarket Morrisons will be decided at an auction on Saturday, when two U.S. private equity groups will go head-to-head in up to five rounds of bids.Britain's Takeover...

Read more
20 Sep 2021 13:35

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

Read more
16 Sep 2021 11:29

TOP NEWS SUMMARY: Tobacco maker Philip Morris wins asthma firm Vectura

TOP NEWS SUMMARY: Tobacco maker Philip Morris wins asthma firm Vectura

Read more
16 Sep 2021 09:07

TOP NEWS: Vectura shareholders accept Philip Morris takeover

TOP NEWS: Vectura shareholders accept Philip Morris takeover

Read more
16 Sep 2021 08:02

Philip Morris seals contentious Vectura takeover

(Sharecast News) - Philip Morris International has taken control of Vectura after the cigarette company's contentious bid was supported by owners of almost 75% of the inhaler maker's shares.

Read more
16 Sep 2021 07:33

UPDATE 3-Philip Morris seals deal for UK's Vectura despite health group concerns

* Holders of roughly 75% Vectura shares tender support* PMI needed 50% backing for deal to go through* Extends deadline for other holders to tender shares by Sept. 30 (Adds comment from health group; background on deal)By Pushkala Aripaka and Siddh...

Read more
16 Sep 2021 07:33

UPDATE 2-Tobacco firm Philip Morris seals deal for UK's Vectura with 75% support

* Holders of roughly 75% Vectura shares tender support* PMI needed 50% backing for deal to go through* Extends deadline for other holders to tender shares by Sept. 30 (Adds detail, background)By Pushkala AripakaSept 16 (Reuters) - Cigarette maker P...

Read more
14 Sep 2021 18:24

IN BRIEF: Philip Morris gets Japanese regulatory approval for Vectura

IN BRIEF: Philip Morris gets Japanese regulatory approval for Vectura

Read more
8 Sep 2021 07:49

UPDATE 3-$10 bln U.S. battle for Britain's Morrisons heads for auction

* Morrisons agreed CD&R's 7 bln stg offer last month* Rival suitor Fortress considering options* All parties talking to Takeover Panel regarding auction* Morrisons shares trading above CD&R's offer (Adds detail, shares)By James DaveyLONDON, Sept 8 (...

Read more
8 Sep 2021 07:49

UPDATE 2-$10 bln U.S. battle for Britain's Morrisons heads for auction

* Morrisons agreed CD&R's 7 bln stg offer last month* Rival suitor Fortress considering options* All parties talking to Takeover Panel regarding auction* Morrisons shares trading above CD&R's offer (Adds details, shares)By James DaveyLONDON, Sept 8 ...

Read more
8 Sep 2021 07:28

UPDATE 2-UK's Smiths to sell medical division to ICU for $2.4 bln, snubs TA

* Smiths Group agrees sale of unit to ICU Medical* Withdraws recommendation for TA Associates deal* Shares up 4%, biggest riser on the FTSE 100 index (Adds shares, ICU Medical statement, background)By Yadarisa ShabongSept 8 (Reuters) - British indus...

Read more
19 Aug 2021 14:32

Philip Morris snaps up more Vectura shares ahead of deal deadline

(Sharecast News) - US tobacco giant Philip Morris has bought up more shares of London-listed inhaler maker Vectura.

Read more
19 Aug 2021 10:47

Philip Morris lifts Vectura stake to 29%, halts further market trades

Philip Morris lifts Vectura stake to 29%, halts further market trades

Read more
18 Aug 2021 10:27

Philip Morris buys 23% Vectura stake ahead of contentious vote on deal

Philip Morris buys 23% Vectura stake ahead of contentious vote on deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.